Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs

NCT02597387 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed DLBCL and PT/NKCLs

Interventions

DRUG: Mitoxantrone HCL Liposome Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.